You cannot fix what you cannot count. Every donor-funded cancer programme should fund and require a population-based cancer registry so results can be measured over time.
Fewer than one in five people in Africa are covered by a high-quality population-based cancer registry, so GLOBOCAN estimates for the uncovered countries are extrapolations. Registries are cheap relative to treatment programmes and are the only way to see stage shift, survival, and coverage. The proposal is a coordinated donor policy: a fixed percentage of every cancer grant supports a registry meeting IARC Global Initiative for Cancer Registry Development standards, with data deposited in the Global Cancer Observatory.
Shares GLOBOCAN / Global Cancer Observatory, International Agency for Research on Cancer (IARC / WHO), Data silos, Most of the world has almost no cancer care.
Shares GLOBOCAN / Global Cancer Observatory, International Agency for Research on Cancer (IARC / WHO), Most of the world has almost no cancer care.
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results), International Agency for Research on Cancer (IARC / WHO), Data silos.
Shares SEER (Surveillance, Epidemiology, and End Results), Weak real-world evidence and registries, Data silos.
Shares GLOBOCAN / Global Cancer Observatory, SEER (Surveillance, Epidemiology, and End Results), Weak real-world evidence and registries.
Shares GLOBOCAN / Global Cancer Observatory, International Agency for Research on Cancer (IARC / WHO), Data silos.
Shares GLOBOCAN / Global Cancer Observatory, Weak real-world evidence and registries, Most of the world has almost no cancer care.